Truist Financial Corp Bio Techne Corp Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

A detailed history of Truist Financial Corp transactions in Bio Techne Corp stock. As of the latest transaction made, Truist Financial Corp holds 20,861 shares of TECH stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,861

Previous 21,360 2.34%

Holding current value

$1.53 Million

Previous $1.53 Million 8.95%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$70.96 - $82.35 $35,409 - $41,092	-499 Reduced 2.34%	20,861 $1.67 Million
Q2 2024 Aug 20, 2024	SELL	$62.12 - $84.15 $29,755 - $40,307	-479 Reduced 2.19%	21,360 $1.53 Million
Q1 2024 May 10, 2024	BUY	$65.98 - $77.09 $59,052 - $68,995	895 Added 4.27%	21,839 $1.54 Million
Q4 2023 Feb 02, 2024	BUY	$52.83 - $78.22 $45,803 - $67,816	867 Added 4.32%	20,944 $1.62 Million
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $120,590 - $159,704	1,786 Added 9.76%	20,077 $1.37 Million
Q2 2023 Aug 01, 2023	SELL	$73.76 - $85.98 $191,554 - $223,290	-2,597 Reduced 12.43%	18,291 $1.49 Million
Q1 2023 May 05, 2023	SELL	$71.62 - $86.62 $414,966 - $501,876	-5,794 Reduced 21.72%	20,888 $1.55 Million
Q4 2022 Feb 17, 2023	BUY	$80.67 - $352.29 $1.62 Million - $7.07 Million	20,062 Added 303.05%	26,682 $2.21 Million
Q3 2022 Oct 26, 2022	SELL	$282.54 - $391.85 $98,889 - $137,147	-350 Reduced 5.02%	6,620 $1.88 Million
Q2 2022 Jul 22, 2022	SELL	$322.67 - $449.65 $322,992 - $450,099	-1,001 Reduced 12.56%	6,970 $2.42 Million
Q1 2022 Apr 22, 2022	SELL	$353.85 - $487.79 $25,831 - $35,608	-73 Reduced 0.91%	7,971 $3.45 Million
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $607,135 - $698,854	1,331 Added 19.83%	8,044 $4.16 Million
Q3 2021 Nov 05, 2021	SELL	$444.87 - $538.88 $239,340 - $289,917	-538 Reduced 7.42%	6,713 $3.25 Million
Q2 2021 Aug 16, 2021	SELL	$387.35 - $450.26 $33,699 - $39,172	-87 Reduced 1.19%	7,251 $3.27 Million
Q1 2021 May 17, 2021	BUY	$314.62 - $411.0 $48,136 - $62,883	153 Added 2.13%	7,338 $2.8 Million
Q4 2020 Nov 19, 2021	SELL	$246.9 - $321.87 $380,719 - $496,323	-1,542 Reduced 17.67%	7,185 $2.28 Million
Q4 2020 Feb 18, 2021	BUY	$246.9 - $321.87 $133,819 - $174,453	542 Added 6.62%	8,727 $2.77 Million
Q3 2020 Nov 13, 2020	BUY	$232.22 - $282.96 $187,169 - $228,065	806 Added 10.92%	8,185 $2.03 Million
Q2 2020 Aug 14, 2020	BUY	$185.43 - $279.56 $181,721 - $273,968	980 Added 15.31%	7,379 $1.95 Million
Q1 2020 May 15, 2020	BUY	$161.17 - $221.51 $9,670 - $13,290	60 Added 0.95%	6,399 $1.21 Million
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $815,813 - $955,209	4,301 Added 211.04%	6,339 $1.39 Million
Q3 2019 Oct 31, 2019	SELL	$183.56 - $216.72 $7,342 - $8,668	-40 Reduced 1.92%	2,038 $399,000
Q2 2019 Jul 24, 2019	SELL	$188.72 - $215.43 $32,082 - $36,623	-170 Reduced 7.56%	2,078 $433,000
Q4 2018 Jan 22, 2019	BUY	$132.75 - $203.8 $146,025 - $224,180	1,100 Added 95.82%	2,248 $325,000
Q3 2018 Oct 17, 2018	BUY	$147.44 - $204.11 $169,261 - $234,318	1,148 New	1,148 $234,000

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Bio Techne Corp Transaction History